NCT02882828View on ClinicalTrials.gov

PK Assessment of Tacrolimus Exposure Before and After a Switch From Twice Daily Immediate-release (Prograf®) to Once-daily Prolonged Release Tacrolimus (Envarsus®)

PHASE4CompletedINTERVENTIONAL

Enrollment

140

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

March 31, 2020

Study Completion Date

March 31, 2020

Conditions

Allograft

Interventions

DRUG

switched from Prograf® to Envarsus®

Trial Locations (9)

Unknown

University Hospital of Amiens, Amiens

University Hospital of Bordeaux, Bordeaux

University Hospital of Lille, Lille

AP-HP, Paris

University Hospital of Poitiers, Poitiers

University Hospital of Reims, Reims

University Hospital of Rouen, Rouen

University Hospital of Tours, Tours

87 042

Limoges Hospital, Limoges

All Listed Sponsors

lead

University Hospital, Limoges

OTHER

NCT02882828 - PK Assessment of Tacrolimus Exposure Before and After a Switch From Twice Daily Immediate-release (Prograf®) to Once-daily Prolonged Release Tacrolimus (Envarsus®) | Biotech Hunter | Biotech Hunter